B7-H3’s prognostic capacity has been reported for non-small cell lung cancer, prostate cancer, colorectal cancer, and melanoma [12,14,15,16,17,18,19,20,21,22,23,24,25]. Here, CD276 is linked to non-small cell lung carcinoma.